Found 24 matching trials
Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease PHASE4 Rationale: Visual hallucinations (VH) are the most common non-motor symptom...
Show More Location
Academic Medical Center
Learn More & Join Trial
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease PHASE1 This study is being conducted to determine the safety, tolerability, and ph...
Show More Location
Pacific Research Network, Inc.
Learn More & Join Trial
Rivastigmine Study in Adolescents With Down Syndrome PHASE1 The purpose of this study is to determine if short term use of rivastigmine...
Show More Location
Kennedy Krieger Institute
Learn More & Join Trial
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease PHASE3 The purpose of this study was to investigate the 5cm\^2 and 10cm\^2 doses o...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium PHASE2 Antimuscarinic delirium (AMD) is a common and dangerous toxicology conditio...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 PHASE4 The core study assessed the efficacy of a higher dose of rivastigmine 13.3 ...
Show More Location
Clinical Research Advantage Inc./Neurological. Physicians of Arizona, Inc
Learn More & Join Trial
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy PHASE2 This Phase II, multicenter, randomized, double-blind, parallel-group, place...
Show More Location
Advanced Research Center, Inc.;In-Patient Unit
Learn More & Join Trial
Mild Cognitive Impairment in Parkinson's Disease PHASE4 Mild cognitive impairment, including difficulty with solving problems, plan...
Show More Location
University of Pennsylvania, Ralston House
Learn More & Join Trial
Toward a Computationally-Informed, Personalized Treatment for Hallucinations EARLY_PHASE1 Auditory hallucinations are among the most distressing aspects of psychotic...
Show More Location
Connecticut Mental Health Center
Learn More & Join Trial
Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) PHASE2 The purpose of this multicenter trial is to assess the efficacy and safety ...
Show More Location
Multiple Locations
Learn More & Join Trial